Proactively Engaging with AI: A Large-scale Survey by SSE on 100 Listed Private Enterprises

Translated from Securities Times, Zhang Shuxian

The large-scale survey of 100 private enterprises listed on the Shanghai Stock Exchange (SSE) is vigorously underway. SSE has ventured deeply into the core operations of these enterprises, focusing on key issues to promote problem resolution and bolster development confidence among private enterprises.

Shanghai's Private Enterprises Strategically Invest in AI Technologies

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma) is at the forefront of integrating world-leading large model technology, with access to DeepSeek R1 and the independent launch of the PharmAID decision-support platform. These efforts ensure that Fosun Pharma addresses multifaceted challenges in pharmaceutical research and development (R&D). The company is expediting the enhancement of competencies in "commercial value-aided decision-making for pharmaceutics." According to Wu Yifang, Chairman of Fosun Pharma, artificial intelligence (AI) is poised to revolutionize the landscape of pharmaceutical R&D.

In the consumer electronics sector, Shanghai Longcheer Technology Co., Ltd. (Longcheer) is prioritizing strategic engagement with smart wearable products, such as AI/augmented reality (AR) glasses. As a leading original design manufacturer (ODM) in smart products, Longcheer collaborates with partners to develop various AI/AR glasses, producing numerous bestseller items. Furthermore, it is working alongside XREAL and others on the joint development of innovative terminals. Board secretary Zhou Liangliang stated that AI is driving the growth of smart terminal technology. The company has been strategizing in this field for years, and a significant increase in shipments has been observed since last year.

Large-scale Survey on 100 Listed Private Enterprises: Assessing Demands and Gathering Insights

The visits to Fosun Pharma and Longcheer exemplify this initiative. SSE has launched a new research initiative targeting private listed companies. By the end of March, SSE aims to engage with 100 private enterprises listed on the SSE to gather insights and ascertain their needs. During these engagements, the SSE identified needs, communicated policies, and collected feedback from private companies on topics such as AI database enhancement, reducing financing costs, and improving information disclosure standards. Guan Xiaohui, Vice Chairman of Fosun Pharma, emphasized the need for pharmaceutical companies to increase their database capacities to maximize AI's effectiveness in pharmaceutical R&D. SSE is set to accurately assess the demands of private enterprises, furnishing them with policy guidance and services. By leveraging the functionalities of the capital market, it aims to provide diverse financing options and serve as a communication bridge between enterprises, governmental bodies, and financial institutions. This initiative seeks to forge a robust alliance to bolster the development of the private economy through the strategic sharing of information and resources.

Private Enterprises Constitute Half of the SSE Listings

The representation of private enterprises in Shanghai has grown significantly, with nearly 70% of newly listed companies over the past three years being private, including industry leaders like United Imaging Healthcare. Currently, private enterprises constitute about 1,200 of the companies listed on the SSE, exceeding 50% of the total listed companies, with a collective market capitalization of approximately 14 trillion yuan. In the first three quarters of 2024, the revenue generated by private enterprises listed on the SSE amounted to 5.37 trillion yuan, with R&D expenditures reaching 193.5 billion yuan, demonstrating significant growth. Private enterprises dedicated to technological innovation represent 27% of the market. These companies play a vital role in crucial segments of the industrial chain, particularly in areas such as integrated circuits and automobiles. Notable names include Will Semiconductor, GigaDevice, Hangzhou Silan Microelectronics, Great Wall Motor, Yutong Bus, Fuyao Glass, and Joyson Electronics. These enterprises significantly bolster the SSE's industrial advancement and innovation development.

The above information is provided for reference purposes only and does not constitute investment advice.